EverSource Wealth Advisors’s Gilead Sciences GILD Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $546K | Buy |
4,925
+1,194
| +32% | +$132K | 0.02% | 419 |
|
|
2025
Q1 | $418K | Buy |
3,731
+1,332
| +56% | +$149K | 0.02% | 430 |
|
|
2024
Q4 | $222K | Buy |
2,399
+167
| +7% | +$15.4K | 0.01% | 619 |
|
|
2024
Q3 | $187K | Sell |
2,232
-467
| -17% | -$39.2K | 0.01% | 581 |
|
|
2024
Q2 | $205K | Sell |
2,699
-415
| -13% | -$31.6K | 0.01% | 549 |
|
|
2024
Q1 | $203K | Sell |
3,114
-181
| -5% | -$11.8K | 0.02% | 482 |
|
|
2023
Q4 | $267K | Buy |
3,295
+211
| +7% | +$17.1K | 0.02% | 368 |
|
|
2023
Q3 | $231K | Buy |
3,084
+85
| +3% | +$6.37K | 0.02% | 365 |
|
|
2023
Q2 | $231K | Buy |
2,999
+14
| +0.5% | +$1.08K | 0.03% | 371 |
|
|
2023
Q1 | $248K | Buy |
2,985
+84
| +3% | +$6.97K | 0.03% | 339 |
|
|
2022
Q4 | $249K | Sell |
2,901
-586
| -17% | -$50.3K | 0.04% | 321 |
|
|
2022
Q3 | $215K | Buy |
3,487
+1,843
| +112% | +$114K | 0.05% | 288 |
|
|
2022
Q2 | $100K | Buy |
1,644
+568
| +53% | +$34.6K | 0.03% | 376 |
|
|
2022
Q1 | $64K | Buy |
1,076
+27
| +3% | +$1.61K | 0.02% | 427 |
|
|
2021
Q4 | $76K | Buy |
+1,049
| New | +$76K | 0.02% | 349 |
|